Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Status: | Completed |
---|---|
Conditions: | Pneumonia, Infectious Disease, Hospital, Pulmonary |
Therapuetic Areas: | Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases, Other |
Healthy: | No |
Age Range: | Any |
Updated: | 4/2/2016 |
Start Date: | December 2004 |
End Date: | January 2009 |
Contact: | Brian K Walsh, BS, RRT |
Email: | bkw2j@virginia.edu |
Phone: | 434-243-9324 |
Phase 2 Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Given the possible prognostic relationship between exhaled breath condensate pH and clinical
symptoms, it is quite plausible that exhaled breath condensate pH can prove useful in the
intensive care unit. For example, if exhaled breath condensate pH falls prior to the onset
of clinical symptoms, it is likely that it can be useful as an early marker, heralding the
onset of various inflammatory lung diseases. Specifically, exhaled breath condensate pH
could be used as a safe, non-invasive screening tool for Ventilator Associated Pneumonia.
Similarly, just as changes in exhaled breath condensate pH might predict the onset of
disease, exhaled breath condensate pH changes might also mark the progression or resolution
of disease (e.g. alerting clinicians to possible readiness for extubation). Although such
notions are hypothetical, they are beginning to be supported by anecdotal evidence.
symptoms, it is quite plausible that exhaled breath condensate pH can prove useful in the
intensive care unit. For example, if exhaled breath condensate pH falls prior to the onset
of clinical symptoms, it is likely that it can be useful as an early marker, heralding the
onset of various inflammatory lung diseases. Specifically, exhaled breath condensate pH
could be used as a safe, non-invasive screening tool for Ventilator Associated Pneumonia.
Similarly, just as changes in exhaled breath condensate pH might predict the onset of
disease, exhaled breath condensate pH changes might also mark the progression or resolution
of disease (e.g. alerting clinicians to possible readiness for extubation). Although such
notions are hypothetical, they are beginning to be supported by anecdotal evidence.
The investigators have developed a method of collecting exhaled breath condensate pH
continually from ventilated patients, which (1) takes samples from an exhaust port on the
outside of the ventilator circuit, and (2) possesses no measurable resistance to the
ventilator circuit (and, therefore the sampling procedure in no way affects the patient).
Now, additionally, we have performed the continuous collection process on 10 patients in the
intensive care units, none of whom have had any ill effects from the collection process.
The placement of the exhaled breath condensate collection device on the ventilator exhaust
port offers a simplified, accurate, and safe method of investigating the relationships
between airway pH and various pulmonary inflammatory disease processes in intubated patients
of all ages.
In order to further extend our study of airway pH in intubated subjects, we believe it is
necessary to obtain more frequent exhaled breath condensate pH measurements from intubated
subjects. To that end, we have developed a collection system that will also measure the pH
of the collected exhaled breath condensate in a fashion similar to the methodology used for
thousands of assays in our laboratory and other laboratories globally. This involves
deaeration of the sample to remove carbon dioxide. In the lab environment, this is performed
with Argon. In the ICU setting, we will accomplish the same effect by using wall oxygen.
The continuous exhaled breath condensate pH collection and assay system consists of a
condenser attached to the exhaust port of the ventilator. The condenser is kept chilled to
slightly above freezing temperature by a refrigeration system commonly employed in ICU
settings. The collection device stays attached to the exhalation port of the ventilator
continuously, for hours to days.
Collected exhaled breath condensate is channeled into two deaeration chambers, through which
wall oxygen is bubbled (total flow of 1 liter/min). In the second deaeration chamber, a
micro pH electrode is inserted. This pH electrode is attached to a pH recorder that has
internal memory that can record essentially an infinite number of measurements, allowing for
any length duration of monitoring. This recorder has been evaluated by clinical engineering
for radio frequency and other interference and is cleared for hospital use.
After measurement of pH, exhaled breath condensate is channeled into a waste chamber.
The breath condensate collection system is maintained chilled by a "hospital grade"
Electri-Cool II model 767 refrigerated cooling system (or near-equivalent) that is
clinically approved for use in the intensive care units. This device is approximately 30 cm
on a side, and is kept on a wheeled cart out of the way of any clinical activity.
Hypothesis to be Tested: Clearly state the objectives and hypotheses and clearly define the
primary and any secondary outcome measures.
1. Exhaled breath condensate pH will have greater within-hour variability in subjects with
lung disease than in subjects intubated for non-pulmonary reasons.
2. Exhaled breath condensate pH will rise prior to readiness for extubation in infants and
toddlers requiring mechanical ventilation for acute bronchiolitis.
3. A decline in exhaled breath condensate pH or an increase in exhaled breath condensate
pH variability will predict the onset of pulmonary inflammatory processes (such as
ventilator-associated pneumonia) in those who initially require mechanical ventilation
for non-inflammatory reasons.
continually from ventilated patients, which (1) takes samples from an exhaust port on the
outside of the ventilator circuit, and (2) possesses no measurable resistance to the
ventilator circuit (and, therefore the sampling procedure in no way affects the patient).
Now, additionally, we have performed the continuous collection process on 10 patients in the
intensive care units, none of whom have had any ill effects from the collection process.
The placement of the exhaled breath condensate collection device on the ventilator exhaust
port offers a simplified, accurate, and safe method of investigating the relationships
between airway pH and various pulmonary inflammatory disease processes in intubated patients
of all ages.
In order to further extend our study of airway pH in intubated subjects, we believe it is
necessary to obtain more frequent exhaled breath condensate pH measurements from intubated
subjects. To that end, we have developed a collection system that will also measure the pH
of the collected exhaled breath condensate in a fashion similar to the methodology used for
thousands of assays in our laboratory and other laboratories globally. This involves
deaeration of the sample to remove carbon dioxide. In the lab environment, this is performed
with Argon. In the ICU setting, we will accomplish the same effect by using wall oxygen.
The continuous exhaled breath condensate pH collection and assay system consists of a
condenser attached to the exhaust port of the ventilator. The condenser is kept chilled to
slightly above freezing temperature by a refrigeration system commonly employed in ICU
settings. The collection device stays attached to the exhalation port of the ventilator
continuously, for hours to days.
Collected exhaled breath condensate is channeled into two deaeration chambers, through which
wall oxygen is bubbled (total flow of 1 liter/min). In the second deaeration chamber, a
micro pH electrode is inserted. This pH electrode is attached to a pH recorder that has
internal memory that can record essentially an infinite number of measurements, allowing for
any length duration of monitoring. This recorder has been evaluated by clinical engineering
for radio frequency and other interference and is cleared for hospital use.
After measurement of pH, exhaled breath condensate is channeled into a waste chamber.
The breath condensate collection system is maintained chilled by a "hospital grade"
Electri-Cool II model 767 refrigerated cooling system (or near-equivalent) that is
clinically approved for use in the intensive care units. This device is approximately 30 cm
on a side, and is kept on a wheeled cart out of the way of any clinical activity.
Hypothesis to be Tested: Clearly state the objectives and hypotheses and clearly define the
primary and any secondary outcome measures.
1. Exhaled breath condensate pH will have greater within-hour variability in subjects with
lung disease than in subjects intubated for non-pulmonary reasons.
2. Exhaled breath condensate pH will rise prior to readiness for extubation in infants and
toddlers requiring mechanical ventilation for acute bronchiolitis.
3. A decline in exhaled breath condensate pH or an increase in exhaled breath condensate
pH variability will predict the onset of pulmonary inflammatory processes (such as
ventilator-associated pneumonia) in those who initially require mechanical ventilation
for non-inflammatory reasons.
Inclusion Criteria:
- Any intubated patients, aged birth to adulthood, who are on a ventilator in any
University of Virginia (UVA) intensive care unit.
Exclusion Criteria:
- Control subjects may not be taking oral or inhaled steroids or have asthma, chronic
obstructive pulmonary disease (COPD), cystic fibrosis, bacterial or viral
pneumonitis, or adult respiratory distress syndrome (ARDS).
We found this trial at
1
site
University of Virginia The University of Virginia is distinctive among institutions of higher education. Founded...
Click here to add this to my saved trials